(Q43868699)

English

Psychomotor slowing, neuroendocrine responses, and behavioral changes after oral administration of meta-chlorophenylpiperazine in normal volunteers

scientific article published in December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Psychomotor slowing, neuroendocrine responses, and behavioral changes after oral administration of meta-chlorophenylpiperazine in normal volunteers (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

behavioural change

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

author name string

Sabbe B

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Hulstijn W

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Pier M

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Scharpé S

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Zitman F

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Psychiatry Research

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

105

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

151-163

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Functional interrelationship of serotonin and norepinephrine: cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The influence of ondansetron and m-chlorophenylpiperazine on scopolamine-induced cognitive, behavioral, and physiological responses in young healthy controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased psychological responses and divergent neuroendocrine responses to m-CPP and ipsapirone in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-chlorophenylpiperazine induced changes in locomotor activity are mediated by 5-HT1 as well as 5-HT2C receptors in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic and pharmacodynamic profile of oral and intravenous meta-chlorophenylpiperazine in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serotonin and motor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychomotor slowing and planning deficits in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serotonin and anxiety revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of serotonin antagonists on m-chlorophenylpiperazine-mediated responses in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of m-chlorophenylpiperazine in normal subjects: a dose-response study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

m-Chlorophenylpiperazine as a probe of serotonin function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperresponsivity to the serotonin agonist m-chlorophenylpiperazine in Alzheimer's disease. A controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serotonergic modulation of anticholinergic effects on cognition and behavior in elderly humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of meta-chlorophenylpiperazine on neuroendocrine and behavioral responses in male schizophrenic patients and normal volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of subchronic treatment with valproate on L-5-HTP-induced cortisol responses in mania: evidence for increased central serotonergic neurotransmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of trazodone and fluoxetine in the treatment of major depression: therapeutic pharmacokinetic and pharmacodynamic interactions through formation of meta-chlorophenylpiperazine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Lower baseline plasma cortisol and prolactin together with increased body temperature and higher mCPP-induced cortisol responses in men with pedophilia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pindolol pretreatment blocks stimulation by meta-chlorophenylpiperazine of prolactin but not cortisol secretion in normal men

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative anxiogenic, neuroendocrine, and other physiologic effects of m-chlorophenylpiperazine given intravenously or orally to healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparison of the behavioral effects of oral versus intravenous mCPP administration in OCD patients and the effect of metergoline prior to i.v. mCPP.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Metergoline blocks the behavioral and neuroendocrine effects of orally administered m-chlorophenylpiperazine in patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Fine motor retardation and depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in fine motor retardation in depressed patients treated with fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Depressive retardation and treatment with fluoxetine: assessment of the motor component

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Retardation in depression: assessment by means of simple motor tasks

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of administration of mCPP on psychological, cognitive, cardiovascular, hormonal and MHPG measurements in human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of depersonalization by the serotonin agonist meta-chlorophenylpiperazine.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Psychomotor symptoms of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of serum cholesterol levels on meta-chlorophenylpiperazine-evoked neuroendocrine responses in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Differentiation of cognitive and motor slowing in the Digit Symbol Test (DST): differences between depression and schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

5-HT receptors involved in initiation or modulation of motor patterns: opportunities for drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serotonin function in panic disorder: intravenous administration of meta-chlorophenylpiperazine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2801%2900326-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0165-1781(01)00326-2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43868699&oldid=2104041719"